RAMIN RAHIMI: Open Payments
NPI 1639146624 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$487 in 21 payments from 6 companies in 2025. Trend: 2023 $566 · 2024 $256 · 2025 $487
Food & beverage: $487
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $226 |
| MERZ NORTH AMERICA, INC. | 1 | $152 |
| Braeburn Inc. | 2 | $41 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $28 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: Xeomin, BOTOX, QULIPTA, BRIXADI, JOURNAVX, Belbuca, UBRELVY, AJOVY.
Industry payments across MI — which companies pay providers there.
